Hirohito Tada
Chiba University
CancerRadiologySurgeryOncologyCardiothoracic surgeryRetrospective cohort studyClinical endpointLung cancerSurvival rateChemotherapyCarcinomaLungCisplatinnon-small cell lung cancer (NSCLC)VindesineIrinotecanGefitinibAdenocarcinomaDocetaxelMedicine
107Publications
23H-index
6,479Citations
Publications 106
Newest
#1Tomoyuki Hishida (Keio: Keio University)H-Index: 29
#2Etsuo Miyaoka (UTokyo: University of Tokyo)H-Index: 22
Last. Ichiro Yoshino (Chiba University)H-Index: 44
view all 12 authors...
Source
#1Shinichi Toyooka (Okayama University)H-Index: 61
#2Norihito OkumuraH-Index: 15
Last. Hiroshi Date (Kyoto University)H-Index: 52
view all 16 authors...
Abstract Introduction We conducted a randomized controlled study to compare the survival benefit of paclitaxel plus carboplatin and oral uracil-tegafur (UFT) as adjuvant chemotherapy in resected NSCLC. Methods In an open-label multicenter trial, patients with pathological stage IB to IIIA NSCLC were randomized into a group receiving paclitaxel (175 mg/m 2 ) plus carboplatin (area under the curve 5) every 3 weeks for four cycles (arm A) or a group receiving orally administered UFT (250 mg/m 2 ) d...
7 CitationsSource
#1Naoko OseH-Index: 7
#2Hajime MaedaH-Index: 32
Last. Meinoshin Okumura (Osaka University)H-Index: 50
view all 15 authors...
OBJECTIVES:A thymic neuroendocrine tumour (TNET) is rare, and few comprehensive reports of treatment results have been presented. To clarify the clinicopathological characteristics of TNET in affected patients, outcomes were retrospectively examined using cases accumulated in a multicentre survey. METHODS:Thirty patients (25 men and 5 women) who underwent surgical resection or biopsy procedures at 10 institutions of the Thoracic Surgery Study Group of Osaka University (TSSGO) between January 198...
6 CitationsSource
#1Tomoyuki HishidaH-Index: 29
#2Etsuo Miyaoka (UTokyo: University of Tokyo)H-Index: 22
Last. Ichiro Yoshino (Chiba University)H-Index: 44
view all 13 authors...
Abstract Objectives The purpose of this study was to assess the surgical outcomes according to the extent of mediastinal lymph node dissection for patients with NSCLC by using a nationwide registry database. Methods From among 11,663 patients in a Japanese lung cancer registry study for 2004, 5392 patients with clinical stage (c-stage) I or II NSCLC that was completely resected by lobectomy and either systematic (SND) or lobe-specific nodal dissection (LSD) were enrolled. Patients who received p...
33 CitationsSource
#1Takekazu Iwata (Chiba University)H-Index: 17
#2Ichiro Yoshino (Chiba University)H-Index: 44
Last. Yoichi Nakanishi (Kyushu University)H-Index: 46
view all 29 authors...
Background Idiopathic pulmonary fibrosis (IPF) often accompanies lung cancer, and life-threatening acute exacerbation (AE) of IPF (AE-IPF) is reported to occur in 20 % of IPF patients who undergo lung cancer surgery. Pirfenidone is an anti-fibrotic agent known to reduce disease progression in IPF patients. A phase II study was conducted to evaluate whether perioperative pirfenidone treatment could reduce the incidence of postoperative AE-IPF patients with lung cancer.
46 CitationsSource
#1Johan Vansteenkiste (Katholieke Universiteit Leuven)H-Index: 75
#2Byoung Chul Cho (Yonsei University)H-Index: 46
Last. Nasser K. Altorki (Cornell University)H-Index: 63
view all 30 authors...
Summary Background Fewer than half of the patients with completely resected non-small-cell lung cancer (NSCLC) are cured. Since the introduction of adjuvant chemotherapy in 2004, no substantial progress has been made in adjuvant treatment. We aimed to assess the efficacy of the MAGE-A3 cancer immunotherapeutic in surgically resected NSCLC. Methods In this randomised, double-blind, placebo-controlled trial, we recruited patients aged at least 18 years with completely resected stage IB, II, and II...
187 CitationsSource
#1Tomoyuki HishidaH-Index: 29
#2Etsuo MiyaokaH-Index: 22
Last. Ichiro YoshinoH-Index: 44
view all 13 authors...
Abstract The purpose of this study was to assess the surgical outcomes according to the extent of mediastinal lymph node dissection for NSCLC patients by using a nationwide registry database. From among 11,663 patients in a Japanese lung cancer registry study for 2004, a total of 5,392 patients with c-stage I-II NSCLC that was completely resected by lobectomy and either systematic or lobe-specific nodal dissection (SND or LSD) were enrolled. Patients who received preoperative therapy or who had ...
#1Shinichi Toyooka (Okayama University)H-Index: 61
#2Norihito OkumuraH-Index: 15
Last. Hiroshi Date (Kyoto University)H-Index: 52
view all 15 authors...
8521Background: Previous studies have reported that adjuvant chemotherapy provides a survival benefit in patients with resected non-small cell lung cancer (NSCLC). In Japan, uracil-tegafur (UFT) ha...
Source
#2Makoto TakahamaH-Index: 16
Last. Ken KodamaH-Index: 42
view all 10 authors...
Source
#1Takekazu Iwata (Chiba University)H-Index: 17
#2Ichiro Yoshino (Chiba University)H-Index: 44
Last. Yoichi Nakanishi (Chiba University)H-Index: 1
view all 19 authors...
1 CitationsSource
12345678910
Close Researchers